跳至主要内容
临床试验/NCT05439876
NCT05439876已完成2 期

Getting SMART for Pediatric Epilepsy (Sleep, Melatonin, and Research Trial, SMART)

National Taiwan University Hospital1 个研究点 分布在 1 个国家目标入组 147 人开始时间: 2022年7月18日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
147
试验地点
1
主要终点
Sleep Onset Latency

研究概览

简要总结

The purpose of this study is to evaluate the effect of melatonin for improving sleep in pediatric epilepsy.

详细描述

Sleep disturbances are more prevalent in children with epilepsy whose sleep can be disrupted by seizures occurring during the night and/or during the day. Melatonin is a naturally occurring hormone produced in the pineal which regulates sleep-wake cycles and facilitates quality sleep. Therefore, the purpose of this study is to evaluate the effect of melatonin for improving sleep in pediatric epilepsy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Year 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • - Children aged between 1 and 18 years with a confirmed diagnosis of epilepsy and with sleep problems

排除标准

  • Children who are bedridden with limited mobility
  • Children with liver or kidney dysfunction
  • Children on hypnotics, antidepressants, or anxiolytics within 4 weeks before the baseline clinic visit
  • Adolescent girls who are pregnant or breastfeeding
  • Adolescent girls who have sexual activities but cannot take effective contraceptive measures during the trial

研究组 & 干预措施

Melatonin

Experimental

Melatonin

干预措施: Melatonin (Drug)

Placebo

Placebo Comparator

Placebo

干预措施: Placebo (Drug)

结局指标

主要结局

Sleep Onset Latency

时间窗: 4 weeks

Sleep onset latency was assessed by actigraphy.

次要结局

  • Children's Sleep Disturbance(4 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验